IRIDEX Corporation (IRIX) : Acuta Capital Partners scooped up 354,201 additional shares in IRIDEX Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 1,011,871 shares of IRIDEX Corporation which is valued at $14,206,669.IRIDEX Corporation makes up approximately 6.95% of Acuta Capital Partners’s portfolio.
Other Hedge Funds, Including , Tfs Capital added IRIX to its portfolio by purchasing 35,387 company shares during the most recent quarter which is valued at $496,833. IRIDEX Corporation makes up approx 0.09% of Tfs Capital’s portfolio.Blackrock Investment Management boosted its stake in IRIX in the latest quarter, The investment management firm added 26,686 additional shares and now holds a total of 27,827 shares of IRIDEX Corporation which is valued at $390,691. Blackrock Advisors added IRIX to its portfolio by purchasing 2,090 company shares during the most recent quarter which is valued at $29,344.Thompson Davis boosted its stake in IRIX in the latest quarter, The investment management firm added 14,950 additional shares and now holds a total of 17,550 shares of IRIDEX Corporation which is valued at $262,373. IRIDEX Corporation makes up approx 0.40% of Thompson Davis’s portfolio.
IRIDEX Corporation closed down -0.05 points or -0.33% at $14.88 with 22,575 shares getting traded on Thursday. Post opening the session at $14.81, the shares hit an intraday low of $14.37 and an intraday high of $14.93 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
IRIDEX Corporation is a provider of therapeutic based laser consoles delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company’s ophthalmology products consist of laser consoles delivery devices and consumable instrumentation including laser probes. In addition the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy macular holes retinal tears and detachments) which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation. The Company offers ophthalmology treatments for a number of conditions such as Age-related Macular Degeneration Diabetic Retinopathy Proliferative Glaucoma Retinal Tears and Detachments Retinopathy of Prematurity Ocular Tumors and Macular Holes.